Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 19, 2022
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
[ Fri, Aug 19th 2022
] - WOPRAI
Salveen Richter Maintained (BLUE) at Strong Sell with Increased Target to $3 on, Aug 19th, 2022
Salveen Richter of Goldman Sachs, Maintained "bluebird bio, Inc." (BLUE) at Strong Sell with Increased Target from $2 to $3 on, Aug 19th, 2022.
Salveen has made no other calls on BLUE in the last 4 months.
There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 2 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $10 on, Thursday, August 18th, 2022
- Gena Wang of "Barclays" Upgraded from Sell to Hold and Increased Target to $5 on, Friday, August 5th, 2022
These are the ratings of the 2 analyists that currently disagree with Salveen
- Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $8 on, Tuesday, August 2nd, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 17th, 2022
